Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01559 |
| Species: | Homo sapiens |
| Position : | chr13:150570000-150600000 |
| Year: | 2026 |
| Title: | Targeting super-enhancer-driven MAB21L2 suppresses neuroblastoma growth and migration |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | neuroblastoma |
| PMID: | 41651436 |
| MONDO: | MONDO:0005070 |
| Tissue: | Adrenal gland |
| Tissue Ontology ID: | UBERON:0002369 |
| Cell Source: | SK-N-BE(2) cells |
| CVCL ID: | CVCL_0528 |
| Cell Type: | neuroblastoma cell |
| Cell Ontology ID: | CL:0000031 |
| Experiment Type: | Functional perturbation assay |
| High Throughput Method: | ChIP-seq, RNA-seq |
| Low Throughput Method: | Luciferase reporter assay, RT-RT-qPCR, Western blot |
| Target gene : | MAB21L2 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|